Head and neck cancers - recognition and referral
Exam Tips
- Memorize key 2WW triggers: age >=45 with persistent unexplained hoarseness or unexplained neck lump (laryngeal pathway).
- Oral cancer referral clues: unexplained oral ulcer >3 weeks, persistent unexplained neck lump, or suspicious oral/lip lesion including erythroplakia/erythroleukoplakia (often via urgent dental assessment then 2WW).
- Unexplained thyroid lump warrants suspected thyroid cancer pathway referral within 2 weeks.
- In OSCEs, state explicitly: 'I would not trial prolonged symptomatic treatment if red flags persist; I would refer urgently and safety-net.'
- Use visual revision resources for lesion recognition (e. g, oral erythroplakia/erythroleukoplakia and cervical nodal levels in head-and-neck examination figures).
Definition
Head and neck cancer in primary care usually refers to suspected malignant disease of the larynx, oral cavity, or thyroid that presents with persistent, unexplained local symptoms or neck masses. In UK practice, this topic focuses on early recognition and prompt 2-week-wait referral pathways rather than definitive treatment in general practice, because diagnosis requires specialist assessment and tissue sampling.
Pathophysiology
Most laryngeal and oral cancers are squamous cell carcinomas that develop through stepwise epithelial dysplasia to invasive malignancy after chronic carcinogen exposure (especially tobacco and alcohol), with additional contribution from HPV-related oncogenesis in a subset. These tumours invade locally, spread via lymphatics to cervical nodes, and may later metastasize distantly. Thyroid cancers are biologically distinct: papillary and follicular tumours arise from follicular epithelium (often with MAPK pathway alterations such as BRAF in papillary disease), while medullary carcinoma arises from parafollicular C cells; thyroid lesions commonly present as nodules and may spread to regional lymph nodes.
Risk Factors
- Tobacco smoking
- High alcohol intake (synergistic with smoking for upper aerodigestive tract SCC)
- Male sex for oral/laryngeal cancer epidemiology
- Increasing age (notably referral threshold age >=45 years for unexplained persistent hoarseness/neck lump suggestive of laryngeal cancer)
- HPV infection (especially high-risk subtypes in oropharyngeal disease)
- Betel quid/areca nut chewing
- Poor oral hygiene and chronic mucosal irritation
- Previous head/neck irradiation (important for thyroid malignancy risk)
- Family history/genetic syndromes linked to thyroid cancer (e. g, MEN2 for medullary carcinoma)
Clinical Features
Symptoms
- Persistent unexplained hoarseness (especially age >=45 years)
- Unexplained oral ulceration lasting >3 weeks
- Lump on lip or within oral cavity
- Persistent unexplained neck lump
- Unexplained thyroid lump
- Throat pain, oral bleeding, or progressive local discomfort
- Possible late symptoms: dysphagia, odynophagia, weight loss
Signs
- Red patch (erythroplakia) or red-white patch (erythroleukoplakia) in oral cavity
- Palpable cervical lymphadenopathy
- Visible oral cavity mass or non-healing ulcer with induration
- Diffuse thyroid swelling or discrete thyroid nodule
- Voice change on conversation suggesting glottic involvement
- Advanced disease signs: fixed neck node, trismus, cachexia
Investigations
Management
Lifestyle Modifications
- Do not delay referral while trying empirical treatment for persistent unexplained red-flag symptoms
- Safety-net clearly: advise urgent re-attendance for progression (airway symptoms, enlarging neck mass, dysphagia, bleeding, weight loss)
- Smoking cessation support and alcohol reduction to reduce ongoing carcinogenic exposure and improve treatment outcomes
- Provide written information and involve patient/carer preferences in referral and investigation decisions
Pharmacological Treatment
Analgesia while awaiting specialist assessment
- Paracetamol 1 g orally every 4-6 hours when required (max 4 g/day)
- Ibuprofen 400 mg orally three times daily with food if appropriate (use lowest effective dose for shortest duration)
Supportive only; must not postpone urgent cancer referral. Avoid/paracetamol dose-reduce in significant hepatic impairment or low body weight/frailty; avoid NSAIDs in peptic ulcer disease, severe renal impairment, NSAID-exacerbated asthma, uncontrolled hypertension, heart failure, anticoagulation-related bleeding risk, and in late pregnancy.
Topical oral pain relief (selected oral lesions)
- Benzydamine 0.15% mouthwash 15 mL every 1.5-3 hours as needed (rinse/gargle then spit)
- Benzydamine 0.15% spray 4-8 sprays every 1.5-3 hours as needed
Use for symptom relief only; persistent ulceration/red-white lesions still require urgent dental/2WW pathway. May cause local stinging or numbness; caution in hypersensitivity.
Smoking-cessation pharmacotherapy
- Varenicline: day 1-3, 500 micrograms once daily; day 4-7, 500 micrograms twice daily; then 1 mg twice daily for 12 weeks
- Nicotine replacement therapy (e. g, 21 mg/24 h patch daily with short-acting gum/lozenge as needed)
- Bupropion SR: 150 mg once daily for 6 days, then 150 mg twice daily (start 1-2 weeks before quit date)
Check contraindications and interactions before prescribing. Bupropion is contraindicated in seizure disorders, eating disorders, CNS tumour, and abrupt alcohol/benzodiazepine withdrawal; varenicline can cause nausea and requires counselling about mood/behaviour changes.
Surgical / Interventional
- Diagnostic biopsy of suspicious oral/laryngeal lesion
- Definitive oncological surgery where indicated (e. g, transoral laser microsurgery/partial or total laryngectomy, oral cavity tumour resection with neck dissection, thyroidectomy with nodal surgery for selected thyroid cancers)
- Airway procedures (e. g, tracheostomy) in threatened airway from advanced disease
Complications
- Delayed diagnosis leading to higher-stage disease
- Regional nodal spread and distant metastases
- Airway compromise (especially laryngeal disease)
- Dysphagia, aspiration, malnutrition, and weight loss
- Speech and swallowing impairment after disease progression or treatment
- Psychological morbidity and reduced quality of life
Prognosis
In UK data used for referral guidance, approximate 5-year survival is around 70% for laryngeal cancer and above 90% for thyroid cancer, while oral cancer outcomes are more variable and strongly stage-dependent. Earlier recognition and rapid referral improve the chance of curative treatment and functional preservation.
Sources & References
✅NICE Guidelines(1)
📖Textbook References(20)
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 206)[context]
- Netter F. Netter Atlas of Human Anatomy. A Systems Approach 8ed 2022.pdf(pp. 398, 399)[context]
- Netter F. Netter Atlas of Human Anatomy. A Systems Approach 8ed 2022.pdf(pp. 294, 295)[context]
- Netter F. Netter Atlas of Human Anatomy. A Systems Approach 8ed 2022.pdf(pp. 1617, 1618)[context]
- Netter F. Netter Atlas of Human Anatomy. A Systems Approach 8ed 2022.pdf(pp. 1894, 1895)[context]
- Netter F. Netter Atlas of Human Anatomy. A Systems Approach 8ed 2022.pdf(pp. 472, 473)[context]
- Netter F. Netter Atlas of Human Anatomy. A Systems Approach 8ed 2022.pdf(pp. 1129, 1130)[context]
- Netter F. Netter Atlas of Human Anatomy. A Systems Approach 8ed 2022.pdf(pp. 8, 9)[context]
- _OceanofPDF.com_Netters_Anatomy_-_8th_edition_-_Frank_H_Netter_MD.pdf(pp. 867, 868)[context]
- _OceanofPDF.com_Netters_Anatomy_-_8th_edition_-_Frank_H_Netter_MD.pdf(pp. 1894, 1895)[context]
- _OceanofPDF.com_Netters_Anatomy_-_8th_edition_-_Frank_H_Netter_MD.pdf(pp. 526, 527, 528, 529, 530)[context]
- _OceanofPDF.com_Netters_Anatomy_-_8th_edition_-_Frank_H_Netter_MD.pdf(pp. 1425, 1426)[context]
- _OceanofPDF.com_Netters_Anatomy_-_8th_edition_-_Frank_H_Netter_MD.pdf(pp. 1198, 1199, 1200, 1201)[context]
- _OceanofPDF.com_Netters_Anatomy_-_8th_edition_-_Frank_H_Netter_MD.pdf(pp. 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)[context]
- _OceanofPDF.com_Netters_Anatomy_-_8th_edition_-_Frank_H_Netter_MD.pdf(pp. 507, 508)[context]
- [Oxford Medical Handbooks] Ian Wilkinson, Tim Raine, Kate Wiles, Anna Goodhart, Catriona Ha - Oxford Handbook of Clinical Medicine (2017, Oxford University Press) - libgen.li.pdf(pp. 541)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 667, 668)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 633, 634)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 681, 682)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 710, 711)[context]